Pharmacokinetics, pharmacodynamics and tolerability of ORG 43902 in female volunteers

Trial Profile

Pharmacokinetics, pharmacodynamics and tolerability of ORG 43902 in female volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 31 Oct 2013

At a glance

  • Drugs ORG 43902 (Primary) ; Ethinylestradiol/desogestrel; Ganirelix; Recombinant follicle-stimulating hormone
  • Indications Infertility
  • Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics; Proof of concept
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 31 Oct 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top